×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Module 1: Overview Of Drug Development
Session Chair(s)
Courtland R. LaVallee, MBA
Executive Director, Project Management
Dynavax Technologies, United States
- Objectives Derived From Desired Label
- Regulatory Oversight/Requirements
- Workstreams/Inter-relationships
- Timeline
- Risk/Resources
- Summary
Have an account?